+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronavirus Test Kits Market in North America 2024-2028

  • PDF Icon

    Report

  • 158 Pages
  • September 2024
  • Region: North America
  • TechNavio
  • ID: 5027178
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The coronavirus test kits market in north america is forecasted to grow by USD -1419 million during 2023-2028, accelerating at a CAGR of -71.7% during the forecast period. The report on the coronavirus test kits market in north america provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by integration of COVID-19 testing with routine healthcare check-ups, growing demand of coronavirus test kits due to international travel testing requirements, and government initiatives to boost sales of coronavirus test kits.

The coronavirus test kits market in north america is segmented as below:

By End-user

  • Government
  • Non-government

By Type

  • Rapid test kit
  • RT-PCR
  • Others

By Geographical Landscape

  • North America
This study identifies the launch of new COVID-19 test kits as one of the prime reasons driving the coronavirus test kits market in north america growth during the next few years. Also, rise of digital health solution and advancements in technology to develop rapid and accurate COVID-19 test kits will lead to sizable demand in the market.

The report on the coronavirus test kits market in north america covers the following areas:

  • Coronavirus test kits market in north america sizing
  • Coronavirus test kits market in north america forecast
  • Coronavirus test kits market in north america industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronavirus test kits market in north america vendors that include Abbott Laboratories, Advaite Inc., Becton Dickinson and Co., Biomedomics Inc, bioMerieux SA, Cellex Inc., Co Diagnostics Inc, Cue Health Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Laboratory Corp. of America Holdings, Mammoth Biosciences Inc., MyBioSource Inc., QIAGEN N.V., QuidelOrtho Corp., RayBiotech Life Inc., Robert Bosch GmbH, Sherlock Biosciences, Talis Biomedical Corp, and Thermo Fisher Scientific Inc. Also, the coronavirus test kits market in north america analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Chart on North America: Year-over-year growth 2023-2028 (%)
Data Table on Regional - Market size and forecast 2023-2028 ($ million)
4 Historic Market Size
4.1 Coronavirus Test Kits Market in North America 2018 - 2022
Historic Market Size - Data Table on Coronavirus Test Kits Market in North America 2018 - 2022 ($ million)
4.2 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
6.3 Government - Market size and forecast 2023-2028
Chart on Government - Market size and forecast 2023-2028 ($ million)
Data Table on Government - Market size and forecast 2023-2028 ($ million)
Chart on Government - Year-over-year growth 2023-2028 (%)
Data Table on Government - Year-over-year growth 2023-2028 (%)
6.4 Non-government - Market size and forecast 2023-2028
Chart on Non-government - Market size and forecast 2023-2028 ($ million)
Data Table on Non-government - Market size and forecast 2023-2028 ($ million)
Chart on Non-government - Year-over-year growth 2023-2028 (%)
Data Table on Non-government - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Rapid test kit - Market size and forecast 2023-2028
Chart on Rapid test kit - Market size and forecast 2023-2028 ($ million)
Data Table on Rapid test kit - Market size and forecast 2023-2028 ($ million)
Chart on Rapid test kit - Year-over-year growth 2023-2028 (%)
Data Table on Rapid test kit - Year-over-year growth 2023-2028 (%)
7.4 RT-PCR - Market size and forecast 2023-2028
Chart on RT-PCR - Market size and forecast 2023-2028 ($ million)
Data Table on RT-PCR - Market size and forecast 2023-2028 ($ million)
Chart on RT-PCR - Year-over-year growth 2023-2028 (%)
Data Table on RT-PCR - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape - 2023-2028 (%)
Data Table on Market share By Geographical Landscape - 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.4 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.5 Mexico - Market size and forecast 2023-2028
Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Chart on Mexico - Year-over-year growth 2023-2028 (%)
Data Table on Mexico - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Table on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 Advaite Inc.
Advaite Inc. - Overview
Advaite Inc. - Product / Service
Advaite Inc. - Key offerings
12.5 Becton Dickinson and Co.
Becton Dickinson and Co. - Overview
Becton Dickinson and Co. - Business segments
Becton Dickinson and Co. - Key news
Becton Dickinson and Co. - Key offerings
Becton Dickinson and Co. - Segment focus
12.6 Biomedomics Inc
Biomedomics Inc - Overview
Biomedomics Inc - Product / Service
Biomedomics Inc - Key offerings
12.7 bioMerieux SA
bioMerieux SA - Overview
bioMerieux SA - Product / Service
bioMerieux SA - Key offerings
12.8 Cellex Inc.
Cellex Inc. - Overview
Cellex Inc. - Product / Service
Cellex Inc. - Key offerings
12.9 Co Diagnostics Inc
Co Diagnostics Inc - Overview
Co Diagnostics Inc - Product / Service
Co Diagnostics Inc - Key offerings
12.10 Cue Health Inc.
Cue Health Inc. - Overview
Cue Health Inc. - Product / Service
Cue Health Inc. - Key offerings
12.11 Danaher Corp.
Danaher Corp. - Overview
Danaher Corp. - Business segments
Danaher Corp. - Key news
Danaher Corp. - Key offerings
Danaher Corp. - Segment focus
12.12 DiaSorin SpA
DiaSorin SpA - Overview
DiaSorin SpA - Business segments
DiaSorin SpA - Key news
DiaSorin SpA - Key offerings
DiaSorin SpA - Segment focus
12.13 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.14 Hologic Inc.
Hologic Inc. - Overview
Hologic Inc. - Business segments
Hologic Inc. - Key news
Hologic Inc. - Key offerings
Hologic Inc. - Segment focus
12.15 Laboratory Corp. of America Holdings
Laboratory Corp. of America Holdings - Overview
Laboratory Corp. of America Holdings - Business segments
Laboratory Corp. of America Holdings - Key news
Laboratory Corp. of America Holdings - Key offerings
Laboratory Corp. of America Holdings - Segment focus
12.16 QIAGEN N.V.
QIAGEN N.V. - Overview
QIAGEN N.V. - Product / Service
QIAGEN N.V. - Key news
QIAGEN N.V. - Key offerings
12.17 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on North America: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibits 20: Historic Market Size - Data Table on Coronavirus Test Kits Market in North America 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Five forces analysis - Comparison between 2023 and 2028
Exhibits 25: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 30: Chart on Market condition - Five forces 2023 and 2028
Exhibits 31: Chart on End-user - Market share 2023-2028 (%)
Exhibits 32: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 33: Chart on Comparison by End-user
Exhibits 34: Data Table on Comparison by End-user
Exhibits 35: Chart on Government - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Data Table on Government - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Chart on Government - Year-over-year growth 2023-2028 (%)
Exhibits 38: Data Table on Government - Year-over-year growth 2023-2028 (%)
Exhibits 39: Chart on Non-government - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Data Table on Non-government - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Chart on Non-government - Year-over-year growth 2023-2028 (%)
Exhibits 42: Data Table on Non-government - Year-over-year growth 2023-2028 (%)
Exhibits 43: Market opportunity by End-user ($ million)
Exhibits 44: Data Table on Market opportunity by End-user ($ million)
Exhibits 45: Chart on Type - Market share 2023-2028 (%)
Exhibits 46: Data Table on Type - Market share 2023-2028 (%)
Exhibits 47: Chart on Comparison by Type
Exhibits 48: Data Table on Comparison by Type
Exhibits 49: Chart on Rapid test kit - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on Rapid test kit - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on Rapid test kit - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on Rapid test kit - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on RT-PCR - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on RT-PCR - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on RT-PCR - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on RT-PCR - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 61: Market opportunity by Type ($ million)
Exhibits 62: Data Table on Market opportunity by Type ($ million)
Exhibits 63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 64: Chart on Market share By Geographical Landscape - 2023-2028 (%)
Exhibits 65: Data Table on Market share By Geographical Landscape - 2023-2028 (%)
Exhibits 66: Chart on Geographic comparison
Exhibits 67: Data Table on Geographic comparison
Exhibits 68: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 71: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 72: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 75: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 76: Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Chart on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits 79: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits 80: Market opportunity By Geographical Landscape ($ million)
Exhibits 81: Data Table on Market opportunity By Geographical Landscape ($ million)
Exhibits 82: Impact of drivers and challenges in 2023 and 2028
Exhibits 83: Overview on criticality of inputs and factors of differentiation
Exhibits 84: Overview on factors of disruption
Exhibits 85: Impact of key risks on business
Exhibits 86: Companies covered
Exhibits 87: Matrix on companies position and classification
Exhibits 88: Abbott Laboratories - Overview
Exhibits 89: Abbott Laboratories - Business segments
Exhibits 90: Abbott Laboratories - Key news
Exhibits 91: Abbott Laboratories - Key offerings
Exhibits 92: Abbott Laboratories - Segment focus
Exhibits 93: Advaite Inc. - Overview
Exhibits 94: Advaite Inc. - Product / Service
Exhibits 95: Advaite Inc. - Key offerings
Exhibits 96: Becton Dickinson and Co. - Overview
Exhibits 97: Becton Dickinson and Co. - Business segments
Exhibits 98: Becton Dickinson and Co. - Key news
Exhibits 99: Becton Dickinson and Co. - Key offerings
Exhibits 100: Becton Dickinson and Co. - Segment focus
Exhibits 101: Biomedomics Inc - Overview
Exhibits 102: Biomedomics Inc - Product / Service
Exhibits 103: Biomedomics Inc - Key offerings
Exhibits 104: bioMerieux SA - Overview
Exhibits 105: bioMerieux SA - Product / Service
Exhibits 106: bioMerieux SA - Key offerings
Exhibits 107: Cellex Inc. - Overview
Exhibits 108: Cellex Inc. - Product / Service
Exhibits 109: Cellex Inc. - Key offerings
Exhibits 110: Co Diagnostics Inc - Overview
Exhibits 111: Co Diagnostics Inc - Product / Service
Exhibits 112: Co Diagnostics Inc - Key offerings
Exhibits 113: Cue Health Inc. - Overview
Exhibits 114: Cue Health Inc. - Product / Service
Exhibits 115: Cue Health Inc. - Key offerings
Exhibits 116: Danaher Corp. - Overview
Exhibits 117: Danaher Corp. - Business segments
Exhibits 118: Danaher Corp. - Key news
Exhibits 119: Danaher Corp. - Key offerings
Exhibits 120: Danaher Corp. - Segment focus
Exhibits 121: DiaSorin SpA - Overview
Exhibits 122: DiaSorin SpA - Business segments
Exhibits 123: DiaSorin SpA - Key news
Exhibits 124: DiaSorin SpA - Key offerings
Exhibits 125: DiaSorin SpA - Segment focus
Exhibits 126: F. Hoffmann La Roche Ltd. - Overview
Exhibits 127: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 128: F. Hoffmann La Roche Ltd. - Key news
Exhibits 129: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 130: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 131: Hologic Inc. - Overview
Exhibits 132: Hologic Inc. - Business segments
Exhibits 133: Hologic Inc. - Key news
Exhibits 134: Hologic Inc. - Key offerings
Exhibits 135: Hologic Inc. - Segment focus
Exhibits 136: Laboratory Corp. of America Holdings - Overview
Exhibits 137: Laboratory Corp. of America Holdings - Business segments
Exhibits 138: Laboratory Corp. of America Holdings - Key news
Exhibits 139: Laboratory Corp. of America Holdings - Key offerings
Exhibits 140: Laboratory Corp. of America Holdings - Segment focus
Exhibits 141: QIAGEN N.V. - Overview
Exhibits 142: QIAGEN N.V. - Product / Service
Exhibits 143: QIAGEN N.V. - Key news
Exhibits 144: QIAGEN N.V. - Key offerings
Exhibits 145: Thermo Fisher Scientific Inc. - Overview
Exhibits 146: Thermo Fisher Scientific Inc. - Business segments
Exhibits 147: Thermo Fisher Scientific Inc. - Key news
Exhibits 148: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 149: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 150: Inclusions checklist
Exhibits 151: Exclusions checklist
Exhibits 152: Currency conversion rates for US$
Exhibits 153: Research methodology
Exhibits 154: Information sources
Exhibits 155: Data validation
Exhibits 156: Validation techniques employed for market sizing
Exhibits 157: Data synthesis
Exhibits 158: 360 degree market analysis
Exhibits 159: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the coronavirus test kits market in North America: Abbott Laboratories, Advaite Inc., Becton Dickinson and Co., Biomedomics Inc, bioMerieux SA, Cellex Inc., Co Diagnostics Inc, Cue Health Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Laboratory Corp. of America Holdings, Mammoth Biosciences Inc., MyBioSource Inc., QIAGEN N.V., QuidelOrtho Corp., RayBiotech Life Inc., Robert Bosch GmbH, Sherlock Biosciences, Talis Biomedical Corp, and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is launch of new COVID-19 test kits."

According to the report, one of the major drivers for this market is the integration of COVID-19 testing with routine healthcare check-ups.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Advaite Inc.
  • Becton Dickinson and Co.
  • Biomedomics Inc
  • bioMerieux SA
  • Cellex Inc.
  • Co Diagnostics Inc
  • Cue Health Inc.
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Hologic Inc.
  • Laboratory Corp. of America Holdings
  • Mammoth Biosciences Inc.
  • MyBioSource Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corp.
  • RayBiotech Life Inc.
  • Robert Bosch GmbH
  • Sherlock Biosciences
  • Talis Biomedical Corp
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Coronavirus Test Kits Market 2024-2028 - Product Image

Coronavirus Test Kits Market 2024-2028

  • Report
  • 172 Pages
  • Global
From
Coronavirus Test Kits Market by Product Type, Specimen Type, End-User - Global Forecast 2025-2030 - Product Image

Coronavirus Test Kits Market by Product Type, Specimen Type, End-User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
COVID-19 Detection Kits Market Size, Share & Trends Analysis Report By Product (RT-PCR Assay Kits), By Sample Type (Nasopharyngeal), By Mode (Centralized Testing), By End-use (Laboratories), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

COVID-19 Detection Kits Market Size, Share & Trends Analysis Report By Product (RT-PCR Assay Kits), By Sample Type (Nasopharyngeal), By Mode (Centralized Testing), By End-use (Laboratories), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 110 Pages
  • Global
From
2024-2028 Global Coronavirus Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Coronavirus Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
Hepatitis B and C Diagnostics Market 2024-2028 - Product Image

Hepatitis B and C Diagnostics Market 2024-2028

  • Report
  • 176 Pages
  • Global
From

About the POC COVID Diagnostics Market

The POC COVID Diagnostics market is a subset of the Diagnostics industry, focused on the development and production of point-of-care (POC) tests for the detection of the novel coronavirus. These tests are designed to provide rapid results, allowing for quick diagnosis and treatment of patients. POC COVID Diagnostics tests are typically conducted using a variety of methods, such as antigen tests, antibody tests, and molecular tests. The POC COVID Diagnostics market has seen a surge in demand due to the pandemic, with many companies investing in the development of new tests and technologies. This has led to an increase in the number of companies offering POC COVID Diagnostics tests, as well as an increase in the number of tests available. Some of the companies in the POC COVID Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Roche Diagnostics, and Quidel Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.